NCT00468871View on ClinicalTrials.gov

Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant vs Standardized Therapy

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

April 30, 2002

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions
Non-infectious Uveitis
Interventions
DRUG

fluocinolone acetonide intravitreal implant

surgical intravitreal implant of fluocinolone acetonide

DRUG

corticosteroids and immunosuppressants

Systemic corticosteroids alone or combined with immunosuppressants

All Listed Sponsors
lead

Bausch & Lomb Incorporated

INDUSTRY

NCT00468871 - Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant vs Standardized Therapy | Biotech Hunter | Biotech Hunter